PubRank

Francesco Crea

Author PubWeight™ 19.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007 1.34
2 Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007 1.15
3 Epigenetic gene regulation in stem cells and correlation to cancer. Differentiation 2009 1.11
4 Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. Int J Mol Sci 2013 1.04
5 Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol Cancer Ther 2012 0.98
6 Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients. BMC Cancer 2010 0.93
7 Optical biosensors to analyze novel biomarkers in oncology. J Biophotonics 2011 0.90
8 Pharmacogenomics in non-small-cell lung cancer chemotherapy. Adv Drug Deliv Rev 2009 0.89
9 Histone lysine demethylases in breast cancer. Crit Rev Oncol Hematol 2012 0.87
10 Modeling the acid-base properties of glutathione in different ionic media, with particular reference to natural waters and biological fluids. Amino Acids 2011 0.83
11 Histone code, human growth and cancer. Oncotarget 2012 0.82
12 An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw. Biomark Med 2012 0.80
13 Chelating agents for the sequestration of mercury(II) and monomethyl mercury(II). Curr Med Chem 2014 0.80
14 Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions. Prenat Diagn 2008 0.80
15 EZH2 and cancer stem cells: fact or fiction? Epigenomics 2011 0.79
16 A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma. Oncol Lett 2013 0.79
17 Unequal representation of different unique genomic DNA sequences in the cell-free plasma DNA of individual donors. Clin Biochem 2008 0.78
18 Faithful markers of circulating cancer stem cells: is CD133 sufficient for validation in clinics? J Clin Oncol 2011 0.78
19 Histone modifications, stem cells and prostate cancer. Curr Pharm Des 2014 0.77
20 Supramolecular assemblies based on complexes of nonionic amphiphilic cyclodextrins and a meso-tetra(4-sulfonatophenyl)porphine tributyltin(IV) derivative: potential nanotherapeutics against melanoma. Biomacromolecules 2013 0.77
21 Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells. Chemotherapy 2010 0.75
22 Prognostic value of CD133 caused by mutant K-Ras and B-Raf--letter. Clin Cancer Res 2012 0.75
23 Adsorption of nutrients and cadmium by different minerals: experimental studies and modelling. J Environ Manage 2007 0.75
24 The protonation of polyacrylate in seawater. Analysis of concentration effects. Ann Chim 2005 0.75
25 Methylation of the imprinted GNAS1 gene in cell-free plasma DNA: equal steady-state quantities of methylated and unmethylated DNA in plasma. Clin Chim Acta 2008 0.75
26 Mixing effects on the protonation of some polycarboxylates in NaCl(aq)+KCl(aq) at different ionic strengths. Talanta 2007 0.75
27 Dioxouranium(VI)--carboxylate complexes. Interaction with dicarboxylic acids in aqueous solution: speciation and structure. Ann Chim 2006 0.75
28 Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients. Oncology 2016 0.75